Literature DB >> 17981366

Syntheses of 4-(indole-3-yl)quinazolines: a new class of epidermal growth factor receptor tyrosine kinase inhibitors.

Anja Lüth1, Werner Löwe.   

Abstract

The epidermal growth factor (EGF) family of membrane receptors has been identified as a key element in the complex signaling network that is utilized by various classes of cell-surface receptors. The synthesis and pharmacological results of 4-(indole-3-yl)quinazolines are described. The synthesized compounds are new high potent EGFR-tyrosine kinase inhibitors with excellent cytotoxic properties at different cell lines. Furthermore the 4-(indole-3-yl)quinazolines show some tendencies to inhibit the HER-2 TK, too. Moreover this substance class has remarkable strong fluorescence properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981366     DOI: 10.1016/j.ejmech.2007.09.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Iodine/potassium iodide catalyst for the synthesis of trifluoromethylated quinazolines via intramolecular cyclization of 2,2,2-trifluoro-N-benzyl-N'-arylacetimidamides.

Authors:  Ali Darehkordi; Elham Kazemi
Journal:  Mol Divers       Date:  2019-03-13       Impact factor: 2.943

2.  2-(4-Chloro-phen-yl)-4-phenyl-1,2-di-hydro-quinazoline.

Authors:  Chamseddine Derabli; Raouf Boulcina; Sofiane Bouacida; Hocine Merazig; Abdelmadjid Debache
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-19

3.  Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation.

Authors:  Yung Chang Hsu; Mohane Selvaraj Coumar; Wen-Chieh Wang; Hui-Yi Shiao; Yi-Yu Ke; Wen-Hsing Lin; Ching-Chuan Kuo; Chun-Wei Chang; Fu-Ming Kuo; Pei-Yi Chen; Sing-Yi Wang; An-Siou Li; Chun-Hwa Chen; Po-Chu Kuo; Ching-Ping Chen; Ming-Hsine Wu; Chen-Lung Huang; Kuei-Jung Yen; Yun-I Chang; John T-A Hsu; Chiung-Tong Chen; Teng-Kuang Yeh; Jen-Shin Song; Chuan Shih; Hsing-Pang Hsieh
Journal:  Oncotarget       Date:  2016-12-27

4.  Synthesis, Biological Evaluation and Molecular Docking of Novel Indole-Aminoquinazoline Hybrids for Anticancer Properties.

Authors:  Malose J Mphahlele; Mmakwena M Mmonwa; Abimbola Aro; Lyndy J McGaw; Yee Siew Choong
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

5.  A new synthetic route to original sulfonamide derivatives in 2-trichloromethylquinazoline series: a structure-activity relationship study of antiplasmodial activity.

Authors:  Nicolas Primas; Pierre Verhaeghe; Anita Cohen; Charline Kieffer; Aurélien Dumètre; Sébastien Hutter; Sylvain Rault; Pascal Rathelot; Nadine Azas; Patrice Vanelle
Journal:  Molecules       Date:  2012-07-05       Impact factor: 4.411

6.  Electrosynthesis of Quinazolines and Quinazolinones via an Anodic Direct Oxidation C(sp3)-H Amination/C-N Cleavage of Tertiary Amine in Aqueous Medium.

Authors:  Zhenghong Zhou; Kangfei Hu; Jiawei Wang; Zhibin Li; Yan Zhang; Zhenggen Zha; Zhiyong Wang
Journal:  ACS Omega       Date:  2020-12-01

7.  Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity.

Authors:  Arsenii D Snizhko; Alexander V Kyrychenko; Eugene S Gladkov
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

8.  Copper-catalyzed cross-dehydrogenative coupling between quinazoline-3-oxides and indoles.

Authors:  Qin Yang; Zhijian Yin; Lifang Zheng; Jianjun Yuan; Song Wei; Qiuping Ding; Yiyuan Peng
Journal:  RSC Adv       Date:  2019-02-18       Impact factor: 4.036

9.  Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives.

Authors:  G A Khodarahmi; M Rahmani Khajouei; G H Hakimelahi; D Abedi; E Jafari; F Hassanzadeh
Journal:  Res Pharm Sci       Date:  2012-07

10.  Design and Synthesis of New 5-aryl-4-Arylethynyl-1H-1,2,3-triazoles with Valuable Photophysical and Biological Properties.

Authors:  Mariia M Efremova; Anastasia I Govdi; Valeria V Frolova; Andrey M Rumyantsev; Irina A Balova
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.